Novartis AG is 196.7x more valuable than Palvella Therapeutics, Inc. by market capitalization ($283.13 B vs $1.44 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PVLA | NVS |
|---|---|---|
| Market cap | $1.44 B | $283.13 B |
| US-listed rank | #2360 | #47 |
| Revenue (latest FY) | $42.81M | - |
| Net income (latest FY) | -$41.72M | - |
| Net margin | -97.4% | - |
| SEC filings | 774 | 947 |
Novartis AG is 196.7x more valuable than Palvella Therapeutics, Inc. by market capitalization ($283.13 B vs $1.44 B).
Full pages: Palvella Therapeutics, Inc. and Novartis AG, or browse the full rankings.